Royal Brompton & Harefield NHS Foundation Trust

Population 8,000,000
Beds 373
Income £267,165k
Comprehensive Surplus £1,628k
Operating Surplus £6,900k
PPI Cap 14.4%
PPI £29,117k
Public Members

The trust website [1] gives a full list of private facilities both inpatient and outpatients. Private healthcare is delivered at both [2] the Royal Brompton Hospital [3] (Britten Wing) and Harefield Hospital [4] (20 beds):

If your treatment is at Royal Brompton Hospital go to Level 4, Sydney Street Wing.  Turn right out of the lift area and enter the Private Patients Admission & Reception before the Sir Reginald Wilson and Rose wards.

At Harefield Hospital, go to the Private Patients Office located along the corridor on your right after you enter the main reception on the ground floor.

Children are treated privately on the Rose Ward [5].

The Annual Accounts [6] says:

The Royal Brompton and Harefield NHS Foundation Trust owns 100 per cent of the ordinary share capital of The Chelsea Private Hospital Ltd. The cost of this investment is £100. The Chelsea Private Hospital Ltd is a dormant company. Group accounts have not been prepared.

In March Board [7] papers members of the board indicate that they want to increase private patient (PP) income:

[David Shrimpton, Private Patients Managing Director] said he would be looking to expand PP, if capacity were there, with patients coming from the Middle East where there is currently high demand. Any change would be reflected in the next version of the draft budget.


[Richard Paterson, Finance Director] explained that the plan for PP is actually slightly more ambitious than indicated and is £1.5m more than 11/12 outturn.

The July Board [8] papers are pessimistic about private patient income, noting “deterioration in Private Patient performance in a difficult marketplace” and:

The private sector was not doing well with the foreign market and the local market affected. The foreign market vacillates but should come back. The local market reflected the downturn in the economy. He was not confident this would come back in the near term. In response to a comment from [Sir Robert Finch, Chair] that this would have a serious impact on PP income, [Robert Bell, Chief Executive] said the Trust would have to offer alternative services where the Trust expects the private market to develop.

The Forward Plan [9] also says that the trust intends to increase private patient income:

Another opportunity will be in private patient services where the new Health and Social Care Act has substantially reduced the constraints over growth.

The Forward Plan also says that raising private patient income could help the trust’s financial situation, but says that it would need to formulate a new private patient business plan:

The potential raising of the “cap” on Foundation Trusts’ private patient activity as a percentage of total clinical income to 49% could lead to some financial protection against increasing NHS tariff / volume uncertainty. However maintaining sensible pricing positions while increasing volumes of activity is unlikely to be achieved on a “more of the same” basis, especially with some insurers’ aggressive moves against consultant fee levels and plan coverages. Embassy and overseas patient flows may become contingent on more specialist activities and services we have yet to develop, such as training programmes for overseas medics and nurses. We consequently need to formulate a new strategy for our private patients’ business to address these issues.

On the Royal Brompton & Harefield Charitable Fund, the Forward Plan says:

The financial projections reflect our estimates of the improved donation stream anticipated as a result of these changes. These funds will be available, in particular, to support the Trust’s capital investment plans.

In other words, the trust expects there to be an increased income of charitable funds which it will use for capital projects.

Site Map
Up: Trust profiles